H.C. Wainwright analyst Joseph Pantginis reiterated a Neutral rating on CalciMedica (NASDAQ: CALC).The analyst commented: "CalciMedica announced 2Q26 financial results ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE